| Dietary patterns, cost and compliance with low-protein diet of phenylketonuria and other inherited metabolic diseases T Mlčoch, R Puda, P Ješina, M Lhotáková, Š Štěrbová, T Doležal European journal of clinical nutrition 72 (1), 87-92, 2018 | 39 | 2018 |
| Propensity score weighting using overlap weights: a new method applied to regorafenib clinical data and a cost-effectiveness analysis T Mlcoch, T Hrnciarova, J Tuzil, J Zadak, M Marian, T Dolezal Value in Health 22 (12), 1370-1377, 2019 | 31 | 2019 |
| Medical and productivity costs of rheumatoid arthritis in the Czech Republic: cost-of-illness study based on disease severity J Klimeš, M Vocelka, L Šedová, T Doležal, T Mlčoch, A Petříková, J Vlček Value in health regional issues 4, 75-81, 2014 | 31 | 2014 |
| Cost-of-illness analysis and regression modeling in cystic fibrosis: a retrospective prevalence-based study T Mlčoch, J Klimeš, L Fila, V Vávrová, V Skalická, M Turnovec, V Krulišová, ... The European Journal of Health Economics 18, 73-82, 2017 | 30 | 2017 |
| Mapping the relationship between clinical and quality-of-life outcomes in patients with ankylosing spondylitis T Mlcoch, L Sedova, J Stolfa, M Urbanova, D Suchy, A Smrzova, ... Expert Review of Pharmacoeconomics & Outcomes Research 17 (2), 203-211, 2017 | 19 | 2017 |
| Outcomes according to MSKCC risk score with focus on the intermediate-risk group in metastatic renal cell carcinoma patients treated with first-line sunitinib: a retrospective … O Fiala, J Finek, A Poprach, B Melichar, J Kopecký, M Zemanova, ... Cancers 12 (4), 808, 2020 | 17 | 2020 |
| Mapping quality of life (EQ-5D) from DAPsA, clinical DAPsA and HAQ in psoriatic arthritis T Mlcoch, J Tuzil, L Sedova, J Stolfa, M Urbanova, D Suchy, A Smrzova, ... The Patient-Patient-Centered Outcomes Research 11, 329-340, 2018 | 10 | 2018 |
| Highly innovative drug program in the Czech Republic: description and pharmacoeconomic results—cost-effectiveness and budget impact analyses E Ornstova, M Sebestianova, T Mlcoch, K Lamblova, T Dolezal Value in Health Regional Issues 16, 92-98, 2018 | 9 | 2018 |
| Short-term response in new users of anti-TNF predicts long-term productivity and non-disability: analysis of Czech ATTRA ankylosing spondylitis biologic registry J Tužil, T Mlčoch, J Jirčíková, J Závada, L Nekvindová, M Svoboda, ... Expert Opinion on Biological Therapy 20 (2), 183-192, 2020 | 6 | 2020 |
| Společenské náklady konzumace alkoholu v České republice T Mlčoch, K Chadimová, T Doležal, D Dolejší, B Hájíčková, M Mazalová, ... Praha: iHETA, 2019 | 6 | 2019 |
| Cost-effectiveness analysis of sulodexide in patients with non-proliferative diabetic retinopathy in the Czech Republic K Lamblova, T Mlcoch, M Mazalova, T Dolezal Value in Health 19 (7), A568, 2016 | 5 | 2016 |
| Doporučené postupy pro zdravotně-ekonomická hodnocení v ČR: Česká společnost pro farmakoekonomiku a hodnocení zdravotnických technologií (ČFES) J Klimeš, T Mlčoch, B Pásztor, K Baloghová, Š Veselá, L Bulejová, J Tužil, ... Květen, 2020 | 4 | 2020 |
| PMH32 THE ECONOMIC BURDEN OF ALCOHOL CONSUMPTION IN THE CZECH REPUBLIC K Chadimova, T Mlcoch, D Dolejsi, B Hajickova, M Mazalova, K Lamblová, ... Value in Health 22, S686, 2019 | 4 | 2019 |
| Treatment sequences in metastatic renal cell carcinoma: Efficacy results from the Czech registry (RENIS) J Finek, R Demlova, K Kopeckova, T Buchler, B Melichar, J Prausova, ... Annals of Oncology 29, viii316-viii317, 2018 | 4 | 2018 |
| Novel approach to decision making for orphan drugs B Decker, T Mlcoch, A Pustovalova, T Dolezal International Journal of Technology Assessment in Health Care 39 (1), e10, 2023 | 3 | 2023 |
| Cost-effectiveness analysis of parenteral methotrexate for the treatment of Crohn’s disease T Mlcoch, B Decker, T Dolezal Applied Health Economics and Health Policy 19, 593-604, 2021 | 3 | 2021 |
| The impact of anti-Tnf (etanercept) therapy on work productivity in patients with rheumatoid arthritis, psoriatic arthritis and psoriasis in the Czech Republic T Mlcoch, J Jircikova, M Mandelikova, K Kruntoradova, T Dolezal Value in Health 18 (7), A649, 2015 | 3 | 2015 |
| Cost-Effectiveness Analysis of Ginkgo Biloba Extract (Egb761®-Tanakan®) for The Treatment of Dementia In The Czech Republic K Kruntoradova, M Mandelikova, T Mlcoch, T Dolezal Value in Health 18 (7), A756, 2015 | 3 | 2015 |
| PMD22 COST-EFFECTIVENESS ANALYSIS OF SUCROSE OCTASULFATE (URGOSTART) DRESSING IN THE TREATMENT OF DIABETIC FOOT AND VENOUS LEG ULCERS T Mlcoch, J Bartakova, K Chadimová, E Ornstová, B Hajickova, T Dolezal Value in Health 22, S673, 2019 | 2 | 2019 |
| EE747 Cost-Utility Analysis of 15-Valent Pneumococcal Conjugate Vaccine in the Immunization of Adults Over 65 Years of Age in the Czech Republic G Volfova, T Mlcoch, Š Uherek, K Lamblová, J Zadak, E Vaverkova, ... Value in Health 26 (12), S198, 2023 | 1 | 2023 |
